• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

HealthCare Ventures

edit

HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing high growth potential. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners.

Recent Milestones

edit

• 
  HealthCare Ventures invested in Theraclone Sciences. (3/25/13)
  Posted 3/25/13 at 8:12pm via finsmes.com
• 
  HealthCare Ventures invested in DecImmune Therapeutics. (2/26/13)
  Posted 2/26/13 at 11:25pm via finsmes.com
• 
  HealthCare Ventures invested in GITR. (6/12/12)
  Posted 6/12/12 at 6:07pm via masshightech.com
• 
  HealthCare Ventures invested in Promedior. (3/7/12)
  Posted 3/11/12 at 7:20pm via fiercebiotech.com
• 
  HealthCare Ventures invested in Radius Health. (2/13/12)
  Posted 2/13/12 at 3:07am via onbiovc.com
• 
  HealthCare Ventures invested in Mosaic Biosciences. (11/8/11)
  Posted 7/22/11 at 6:55pm via onbiovc.com
• 
  HealthCare Ventures invested in Pathogenetix. (11/1/11)
  Posted 11/1/11 at 6:55pm via masshightech.com
• 
  HealthCare Ventures invested in Sensors for Medicine and Science. (11/1/11)
  Posted 11/1/11 at 11:15pm via pr-inside.com
• 
  HealthCare Ventures invested in Tensha Therapeutics. (9/12/11)
  Posted 8/8/11 at 6:12pm via finsmes.com
• 
  HealthCare Ventures invested in Cleveland HeartLab. (8/22/11)
  Posted 8/22/11 at 7:28pm via finsmes.com
• 
  HealthCare Ventures invested in Pathogenetix. (8/1/11)
  Posted 8/1/11 at 6:11pm via pathogenetix.com
• 
  HealthCare Ventures invested in Radius Health. (7/26/11)
  Posted 7/26/11 at 5:35pm via onbiovc.com
• 
  HealthCare Ventures invested in nanoMR. (7/19/11)
  Posted 7/19/11 at 5:47am via yahoo.com
• 
  HealthCare Ventures invested in CellNovo. (2/4/11)
  Posted 2/4/11 at 6:11pm via cellnovo.com
• 
  HealthCare Ventures invested in Dicerna Pharmaceuticals. (10/21/10)
  Posted 10/22/10 at 7:01pm via masshightech.com
• 
  HealthCare Ventures invested in DecImmune Therapeutics. (9/27/10)
  Posted 9/27/10 at 11:08pm via finsmes.com

Investments

Videos

Sources

1. Theraclone Sciences Closes $14M in Series B and Debt Financing (finsmes.com) [edit]
2. DecImmune Therapeutics Completes $2.25M Equity Financing (finsmes.com) [edit]
3. GITR gets $1M from HealthCare Ventures (masshightech.com) [edit]
4. Promedior lands $21.5M D round for fibrosis pipeline (fiercebiotech.com) [edit]
5. Radius Health, Inc.: Series C $21.4M (onbiovc.com) [edit]
6. Mosaic Biosciences, Inc.: Series A $1M (onbiovc.com) [edit]
7. PathoGenetix adds $7.5M to Series B funding (masshightech.com) [edit]
8. Sensors for Medicine and Science Raises $54.1 Million Series D Financing (pr-inside.com) [edit]
9. Tensha Therapeutics Raises $15M in Series A Financing (finsmes.com) [edit]
10. Cleveland HeartLab Completes $18.4M Series B Financing Round (finsmes.com) [edit]
11. PathoGenetiX Inc. completes first close of Series B Financing ... (pathogenetix.com) [edit]
12. Radius Health, Inc.: Series C $66M (onbiovc.com) [edit]
13. nanoMR Announces $13 Million Series B Financing (ca.finance.yahoo.com) [edit]
14. CELLNOVO SECURES £30 MILLION IN SERIES B FINANCING (cellnovo.com) [edit]
15. Dicerna makes $29M second close on Series B funding round (masshightech.com) [edit]
16. DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding (finsmes.com) [edit]
17. Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates (anchortx.com) [edit]
18. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
19. Stemgent, Inc.: Series B $5.6M (onbiovc.com) [edit]
20. Trevena, Inc.: Series B $35M (onbiovc.com) [edit]
21. FoldRx banks $29M for neurodegenerative drug application (fiercebiotech.com) [edit]
22. Theraclone Raises $1.5M (xconomy.com) [edit]
23. Seahorse Bioscience, Inc.: Series D $5M (onbiovc.com) [edit]
24. Stemgent issues notes to raise $2.7M (masshightech.com) [edit]
25. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants (ir.pharmathene.com) [edit]
26. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
27. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]
28. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
29. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
30. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million (radiuspharm.mwnewsroom.com) [edit]
31. Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs (reuters.com) [edit]
32. Trevena, Inc. Announces $24 Million Series A Financing (trevenainc.com) [edit]
33. Ascent Therapeutics Secures $8 Million Series A (venturedeal.com) [edit]
34. Radius Raises $57.5 Million in Second Private Financing Round (radiuspharm.com) [edit]
35. Sequoia Pharmaceuticals Raises $35M In Series C Financing (fiercebiotech.com) [edit]
36. VaxInnate Secures $40 Million Series C Financing. (thefreelibrary.com) [edit]
37. EDGAR [edit]
38. AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS (freshnews.com) [edit]
39. CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES (catalystbiosciences.com) [edit]
40. Sequoia Pharmaceuticals Secures Funding to Test its Unique AIDS Drug (articleyoube.com) [edit]